Cerner Collaboration to Increase Access to Cancer Clinical Trials
The company’s Learning Health Network teams with Elligo Health Research and Freenome to Advance Early Cancer Detection KANSAS CITY, Mo. – May 18, 2022 – Cerner Corporation (NASDAQ: CERN), Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection. Together they will be using the research-activated…